Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chamfond Biotech is a China-based healthcare company focused primarily on the research, development, manufacturing, and distribution of medical devices, with stated group-level activities spanning medical devices and biopharmaceuticals. The company markets products used in biopsy procedures, surgical visualization, retractors and consumables, oncological histology workflows, and biomaterials. Publicly visible commercial products include bone marrow biopsy needles, reusable biopsy guns, surgical loupes, medical headlights, self-retaining retractors, and dressings such as porcine acellular dermal matrix and alginate dressings. Chamfond appears to operate as part of the broader Chamfond Group, headquartered in Nanjing, with multiple R&D and production centers and an international sales footprint. Based on available information, Chamfond is best characterized as a commercial-stage medical technology company rather than a therapeutics drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chamfond Biotech.